AQR Arbitrage’s Coeptis Therapeutics Warrants COEPW Stock Holding History

AQR Arbitrage’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45,745	Closed	-$1.74K	–	695
2023 Q3	$1.74K	Sell	45,745 -31,854	-41%	-$1.3K	﹤0.01%	746
2023 Q2	$5.56K	Sell	77,599 -17,437	-18%	-$2.08K	﹤0.01%	782
2023 Q1	$14K	Sell	95,036 -13,225	-12%	-$1.71K	﹤0.01%	813
2022 Q4	$10.8K	Sell	108,261 -21,739	-17%	-$1.45K	﹤0.01%	920
2022 Q3	$4K	Hold	130,000	–	–	﹤0.01%	1275
2022 Q2	$5K	Hold	130,000	–	–	﹤0.01%	1350
2022 Q1	$11K	Buy	130,000 +65,000	+100%	+$10.4K	﹤0.01%	1241
2021 Q4	$650K	Sell	65,000 -65,000	-50%	-$21.6K	0.02%	802
2021 Q3	$34K	Hold	130,000	–	–	﹤0.01%	986
2021 Q2	$70K	Hold	130,000	–	–	﹤0.01%	888
2021 Q1	$56K	Buy	+130,000	New	+$122K	﹤0.01%	889

Other funds holding COEPW

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

AQR Arbitrage's COEPW Position: Q4 2023 in Review

AQR Arbitrage sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2023, closing a stake of 45,745 shares — an estimated $1.74K sold.

AQR Arbitrage first reported a position in COEPW in Q1 2021 and held it in 11 quarters. The position peaked at $650K in Q4 2021. 19 funds tracked by Wall St. Rank hold COEPW as of Q4 2023.

AQR Arbitrage reported no remaining Coeptis Therapeutics Warrants position as of Q4 2023 after selling out during the quarter.
AQR Arbitrage sold 45,745 Coeptis Therapeutics Warrants shares in Q4 2023, an estimated $1.74K.
AQR Arbitrage first reported a position in Coeptis Therapeutics Warrants in Q1 2021 and held it in 11 quarters.
AQR Arbitrage's Coeptis Therapeutics Warrants position peaked at $650K in Q4 2021.
19 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2023.

Based on AQR Arbitrage's 13F filing for Q4 2023, filed 14 Feb 2024.